These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 36698076)
1. The effect of high-dose vitamin D supplementation on hepcidin-25 and erythropoiesis in patients with chronic kidney disease. Pistis KD; Westerberg PA; Qureshi AR; Beshara S; Sterner G; Bárány P; Linde T BMC Nephrol; 2023 Jan; 24(1):20. PubMed ID: 36698076 [TBL] [Abstract][Full Text] [Related]
2. Pilot study of the effect of cholecalciferol supplementation on hepcidin in children with chronic kidney disease: Results of the D-fense Trial. Atkinson MA; Juraschek SP; Bertenthal MS; Detrick B; Furth SL; Miller ER Pediatr Nephrol; 2017 May; 32(5):859-868. PubMed ID: 28013381 [TBL] [Abstract][Full Text] [Related]
3. High-dose vitamin D Smith EM; Alvarez JA; Kearns MD; Hao L; Sloan JH; Konrad RJ; Ziegler TR; Zughaier SM; Tangpricha V Clin Nutr; 2017 Aug; 36(4):980-985. PubMed ID: 27402475 [TBL] [Abstract][Full Text] [Related]
4. The Effect of Vitamin D Supplementation on Hepcidin, Iron Status, and Inflammation in Pregnant Women in the United Kingdom. Braithwaite VS; Crozier SR; D'Angelo S; Prentice A; Cooper C; Harvey NC; Jones KS; Nutrients; 2019 Jan; 11(1):. PubMed ID: 30669280 [TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
6. Impact of supplementation with iron-folic acid (IFA) and vitamin D Ahamed F; Jaiswal A; Sahoo S; Ghosh T; Kaur A; Rehman T; Goswami K BMJ Open; 2024 Apr; 14(4):e080303. PubMed ID: 38626969 [TBL] [Abstract][Full Text] [Related]
8. Effect of Vitamin D Supplementation on Serum Hepcidin Levels in Non-Diabetic Chronic Kidney Disease Patients. Kamboj K; Yadav AK; Kumar V; Jha V Indian J Nephrol; 2023; 33(6):444-448. PubMed ID: 38174303 [TBL] [Abstract][Full Text] [Related]
9. Effect of vitamin D3 supplementation on iron status: a randomized, double-blind, placebo-controlled trial among ethnic minorities living in Norway. Madar AA; Stene LC; Meyer HE; Brekke M; Lagerløv P; Knutsen KV Nutr J; 2016 Aug; 15(1):74. PubMed ID: 27506667 [TBL] [Abstract][Full Text] [Related]
10. High-Dose Vitamin D Smith EM; Jones JL; Han JE; Alvarez JA; Sloan JH; Konrad RJ; Zughaier SM; Martin GS; Ziegler TR; Tangpricha V JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):87-94. PubMed ID: 29505145 [TBL] [Abstract][Full Text] [Related]
11. Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. Gummer J; Trengove R; Pascoe EM; Badve SV; Cass A; Clarke P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW; Olynyk JK; Ferrari P; Nephrology (Carlton); 2017 Jul; 22(7):548-554. PubMed ID: 27171136 [TBL] [Abstract][Full Text] [Related]
12. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study . Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472 [TBL] [Abstract][Full Text] [Related]
13. The Effect of Vitamin D Supplementation on Bone Metabolic Markers in Chronic Kidney Disease. Yadav AK; Kumar V; Kumar V; Banerjee D; Gupta KL; Jha V J Bone Miner Res; 2018 Mar; 33(3):404-409. PubMed ID: 29044707 [TBL] [Abstract][Full Text] [Related]
14. The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D. Samaan F; Carvalho AB; Pillar R; Rocha LA; Cassiolato JL; Cuppari L; Canziani MEF J Ren Nutr; 2019 Sep; 29(5):407-415. PubMed ID: 30686750 [TBL] [Abstract][Full Text] [Related]
15. The Effect of Vitamin D Kasprowicz K; Ratkowski W; Wołyniec W; Kaczmarczyk M; Witek K; Żmijewski P; Renke M; Jastrzębski Z; Rosemann T; Nikolaidis PT; Knechtle B Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32344650 [TBL] [Abstract][Full Text] [Related]
16. Effect of weekly vitamin D supplementation on the severity of atopic dermatitis and type 2 immunity biomarkers in children: A randomized controlled trial. Borzutzky A; Iturriaga C; Pérez-Mateluna G; Cristi F; Cifuentes L; Silva-Valenzuela S; Vera-Kellet C; Cabalín C; Hoyos-Bachiloglu R; Navarrete-Dechent C; Cossio ML; Le Roy C; Camargo CA J Eur Acad Dermatol Venereol; 2024 Sep; 38(9):1760-1768. PubMed ID: 38483248 [TBL] [Abstract][Full Text] [Related]
17. Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial. Gaillard CA; Bock AH; Carrera F; Eckardt KU; Van Wyck DB; Bansal SS; Cronin M; Meier Y; Larroque S; Roger SD; Macdougall IC PLoS One; 2016; 11(6):e0157063. PubMed ID: 27276035 [TBL] [Abstract][Full Text] [Related]
18. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD). Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972 [TBL] [Abstract][Full Text] [Related]
19. Deferasirox and vitamin D Ghaith MM; El-Boshy M; Almasmoum H; Abdelghany AH; Azzeh FS; Almaimani RA; Idris S; Ahmad J; Mahbub AA; BaSalamah MA; Elzubeir ME; Refaat B J Trace Elem Med Biol; 2022 Dec; 74():127085. PubMed ID: 36179462 [TBL] [Abstract][Full Text] [Related]
20. Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): A double-blind, randomized, placebo-controlled clinical trial. Moreira-Lucas TS; Duncan AM; Rabasa-Lhoret R; Vieth R; Gibbs AL; Badawi A; Wolever TM Diabetes Obes Metab; 2017 Jan; 19(1):133-141. PubMed ID: 27717236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]